Bristol-Myers Squibb GmbH & Co. KGaA
Paris (ots/PRNewswire) - Proven biologic is first therapy available in both subcutaneous and intravenous formulations for adults with moderate to severe active rheumatoid arthritis Bristol-Myers Squibb announced today that the European Commission has granted marketing authorisation for the subcutaneous formulation of ORENCIA(R) (abatacept), in combination with ...
London And Boston (ots/PRNewswire) - - EvaluateMedTech(TM) World Preview 2018 Reveals Medtech Sales Growth Rate Forecast to Outperform Global Prescription Drug Market Between 2011 and 2018 EvaluatePharma [http://www.evaluatepharma.com ](R) the premier source for life science sector analysis and consensus forecasts, today released its EvaluateMedTech(TM) World Preview 2018 [http://www.evaluatemedtech.com/MT2018 ] report at ...
Zutphen, The Netherlands (ots/PRNewswire) - Cryo-Save Group promotes the awareness of cord blood storage and stem cell therapies at several local educational events held throughout Europe. Cryo-Save continues its Cord Blood Awareness Months celebration by sponsoring educational events in the Netherlands, Italy and Spain during the months of October and November. It is ...
Vienna, Austria (ots/PRNewswire) - INTENDED FOR EUROPEAN MEDIA ONLY Results from a Phase I/II trial of the investigational compound lenvatinib (E7080), a multi-targeted, kinase inhibitor, in people with advanced hepatocellular cancer have been presented at the ESMO 2012 Congress (European Society for Medical ...
Bristol-Myers Squibb GmbH & Co. KGaA
Princeton, New Jersey (ots/PRNewswire) - - Long-Term Follow Up From Phase 3 Study (024) Demonstrated That 19.0 Percent of Treatment-Naïve Patients Who Received YERVOY at Investigational Dose of 10 mg/kg Plus Dacarbazine (DTIC) Were Alive at Four Years vs. 9.6 Percent of Patients Treated with DTIC Alone - Few New ...
London And Boston (ots/PRNewswire) - EvaluatePharma [http://www.evaluatepharma.com ], the premier source for life science sector analysis and consensus forecasts, today announced the launch of EvaluateMedTech [http://www.evaluatemedtech.com ](TM), a new intelligence service focused on the medical device and diagnostic sector. Powered by EvaluatePharma's proven platform ...
Roggwil, Switzerland (ots) - Colds and flu are the most frequent illnesses experienced by the Western world. They lead to tremendous costs to public health and the economy, being the leading cause of absences from work and school. This is especially the case during the autumn and winter months when almost everyone suffers colds or flu a few times. Immune resistance ...
Calgary, Alberta (ots/PRNewswire) - IVUS data will evaluate plaque regression in patients with Coronary Artery Disease TSX Exchange Symbol: RVX Resverlogix Corp. today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial targeting high-risk cardiovascular disease patients. ASSURE will evaluate the ability of RVX-208, Resverlogix's BET protein inhibitor, to regress atherosclerotic disease versus ...
Chicago (ots/PRNewswire) - The Myxo Etiologix model 5100, also known as the Myxo 5100 is a heart valve device manufactured and introduced to the market by Edwards LifeSciences (Irvine CA) in 2007. This device was specifically designed to treat the Myxo disease, an illness that causes a leaky heart valve. Despite being sold and surgically implanted into patients in the ...
Natick, Massachusetts (ots/PRNewswire) - Innovative Stent Solution to treat patients with Critical Limb Ischemia Boston Scientific has launched in European countries the PROMUS ELEMENT(TM) PLUS BTK (Below The Knee) Everolimus-Eluting Stent System for the treatment of certain severe peripheral artery lesions. The Drug Eluting Stent (DES) has CE Mark approval for both ...
Zutphen, The Netherlands (ots/PRNewswire) - Cryo-Save Group promotes the awareness of cord blood storage and stem cell therapies at several professional conferences held throughout eastern and southern Europe. It is with great pleasure that Cryo-Save supports the awareness, research and advancement of cord blood storage and therapies by taking part in and sponsoring ...
Lugano, Switzerland / Raleigh, N.C., USA (ots) - Gelclair® Strengthens DARA's Growing Portfolio of In-licensed Oncology and Oncology Supportive Care Products The Helsinn Group of Switzerland announced today that it has entered into an exclusive agreement with DARA BioSciences, Inc. (Nasdaq: DARA) for U.S. ...
http://resources.euroadhoc.com/us/xAaSwiA0 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: free trade: Berlin, Open ...
Chicago (ots/PRNewswire) - Dr. Patrick McCarthy of Northwestern recently admitted under oath in a malpractice lawsuit that a patient he operated on in 2006 had a heart attack while receiving an investigational heart device called the Myxo 5100. This admission comes amid years of denials from McCarthy, the hospital ...
Manchester, England (ots/PRNewswire) - Investigational drug study follows earlier study with promising results in mild to moderate Alzheimer's patients TauRx Therapeutics today announced the initiation of a global Phase 3 clinical trial in a type of Frontotemporal Dementia (FTD) also known as Pick's Disease. The announcement, which immediately follows The 8th International Conference on Frontotemporal Dementias, held 5-7 ...
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on cardiovascular disease and overall health, is pleased to announce that the company received a positive response to its lead product VASCAZEN(TM) at the European Society of ...
http://resources.euroadhoc.com/us/PH6rShim issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Janssen-Cilag International NV (Janssen)
Beerse, Belgium (ots/PRNewswire) - Janssen-Cilag International NV (Janssen) today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency (EMA) seeking conditional approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part ...
Munich And Calgary, Alberta (ots/PRNewswire) - -- Significant Increase in Functional HDL Persisted Throughout the 24-week Study Period -- -- Results from ASSURE Study Expected H1 2013, Using IVUS to Measure Regression of Atherosclerotic Plaque -- TSX Exchange Symbol: RVX Resverlogix Corp. today announced that the ...
Paris (ots/PRNewswire) - Boston Scientific Corporation has received CE Mark approval for use of its PRECISION(TM) PLUS SPINAL CORD STIMULATOR (SCS) System in patients with the system and are in need for magnetic resonance imaging (MRI) head-only scans. The PRECISION PLUS SCS System is the world's first rechargeable SCS device. This approval provides physicians with an ...
Paris (ots/PRNewswire) - Boston Scientific Corporation has received CE Mark approval for use of its PRECISION(TM) PLUS SPINAL CORD STIMULATOR (SCS) System, the world's first rechargeable SCS device, in peripheral nerve stimulation for patients with chronic intractable pain of the trunk. Peripheral nerve stimulation ...
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on cardiovascular disease and overall health, is pleased to announce that the company will be exhibiting at the European Society of Cardiology (ESC) Congress 2012 in Munich, Germany August 25-29, 2012, Hall A2 Booth #B440. The ESC ...
http://resources.euroadhoc.com/us/8OrWIbpx http://resources.euroadhoc.com/us/9qJNp19Q issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 ...
Frankfurt, Germany (ots/PRNewswire) - In June UBM signed a partnership agreement with The Swiss Import Promotion Programme (SIPPO), a performance mandate of SECO implemented by the foreign promotion department of OSEC, with the aim of increasing the competitiveness of small and medium size enterprises from emerging markets in developing countries. Through their ...
http://resources.euroadhoc.com/us/QBMtg1Sc http://resources.euroadhoc.com/us/wgWZpOYn issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: ...
Germantown, Maryland (ots/PRNewswire) - A study conducted by researchers from the University of L'Aquila in Italy and Mars, Incorporated provides compelling new evidence that the regular consumption of dietary cocoa flavanols may improve cognitive function in elderly subjects with early memory decline. Just published online in the journal Hypertension, this current ...
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX:PVTTF) (CNSX:PVO), a specialty pharmaceutical company with a focus on cardiovascular health, is pleased to announce that data from a scientific study related to the company's product VASCAZEN(TM) concluded that highly purified Eicosapentaenoic ...
http://resources.euroadhoc.com/us/hAV9r7TT http://resources.euroadhoc.com/us/6L9y8D5x issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: ...
Moscow (ots/PRNewswire) - Inaugural nine recipients of the Prize receive US$27 million in aggregate, all of whom agree to form a Selection Committee to award future prizes The Milner Foundation announces today the launch of the Fundamental Physics Prize Foundation, a not-for-profit corporation ("Foundation") ...
Chicago (ots/PRNewswire) - In the news release, "Enhanced Patient Positioning System Unveiled Further Refining Image Guided Radiation Therapy (IGRT)" issued on 27 Jul 2012 06:00 GMT, by Brainlab over PR Newswire, due to an error by PR Newswire there was a formatting problem with the references. Cone beam CT ...